The first patient with relapsed or refractory acute myeloid leukemia has been dosed with Annamycin plus Cytarabine in the ...

Initial results from the ongoing trial saw one patient achieving a complete response in the trial combining Tovecimig with ...

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to ...

Patients in the trial were split into three groups—those who had a minimal, a partial or a complete response to FLOT chemotherapy before surgery. A patient's initial response was highly ...

High-dose chemotherapy and HSCT can provide long-term benefits in patients with MCL, a retrospective study suggests.

The Montana hospital that fired Dr. Thomas C. Weiner turned over thousands of pages of documents, but members of the board ...

One study showed small cell lung cancer (SCLC) tumors with higher DNA damage response (DDR) activity were initially more ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

“In some cases, chemotherapy-induced nerve damage (neuropathy) can lead to a persistent feeling of cold, particularly in the hands and feet. Additionally, chemotherapy-induced anemia reduces oxygen ...